Literature DB >> 9771445

Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.

M Curling1, S Stenning, C N Hudson, J V Watson.   

Abstract

AIM: To determine if either DNA index or p62c-myc is an independent prognostic variable in ovarian cancer.
METHODS: Multivariate and univariate analyses of the relation between DNA index, p62c-myc, FIGO stage, histological type, tumour grade, completeness of surgery, and patient survival in ovarian cancer were examined.
RESULTS: Multivariate analysis showed significant association of survival only with stage and grade. There was no relation between survival and DNA index.
CONCLUSIONS: DNA index is not an independent prognostic variable in ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771445      PMCID: PMC500749          DOI: 10.1136/jcp.51.6.455

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  59 in total

1.  Prognostic applications of DNA flow cytometry for human solid tumors.

Authors:  O S Frankfurt; S G Arbuck; J L Chin; W R Greco; Z P Pavelic; H K Slocum; A Mittelman; S M Piver; E J Pontes; Y M Rustum
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

2.  Modal DNA value and chromosome number in ovarian neoplasia. A clinical and histopathologic assessment.

Authors:  N B Atkin
Journal:  Cancer       Date:  1971-05       Impact factor: 6.860

3.  Enzyme kinetic studies in cell populations using fluorogenic substrates and flow cytometric techniques.

Authors:  J V Watson
Journal:  Cytometry       Date:  1980-09

4.  c-myc oncogene expression in colorectal cancer.

Authors:  K Sikora; S Chan; G Evan; H Gabra; N Markham; J Stewart; J Watson
Journal:  Cancer       Date:  1987-04-01       Impact factor: 6.860

5.  Flow cytometric DNA ploidy analysis of ovarian granulosa cell tumors.

Authors:  S Chadha; C J Cornelisse; A Schaberg
Journal:  Gynecol Oncol       Date:  1990-02       Impact factor: 5.482

6.  Tumor ploidy as a major prognostic factor in advanced ovarian cancer.

Authors:  C J Rodenburg; C J Cornelisse; P A Heintz; J Hermans; G J Fleuren
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

7.  Patient with 13 chromosome deletion: evidence that the retinoblastoma gene is a recessive cancer gene.

Authors:  W F Benedict; A L Murphree; A Banerjee; C A Spina; M C Sparkes; R S Sparkes
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

8.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

9.  Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.

Authors:  P Hendy-Ibbs; H Cox; G I Evan; J V Watson
Journal:  Br J Cancer       Date:  1987-03       Impact factor: 7.640

10.  Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases.

Authors:  N B Atkin; R Kay
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

View more
  1 in total

Review 1.  c-MYC and Epithelial Ovarian Cancer.

Authors:  Jeyshka M Reyes-González; Pablo E Vivas-Mejía
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.